← Leaderboards
Brian Brooks
National Eye Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Eye Institute
Same institution · by research overlap
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantMolecularAffectSkinPhenotypeAdultChildProtocols DocumentationGeneticCohortFamilyEnrollmentCellsMouse ModelReportingGenesGenotypeVisionGenerationsSamplingUnited States National Institutes Of HealthColobomaEvaluationPlasma
Grant awards (69)
The Genetics of Uveal Coloboma$2,271,643
ZIA · FY2025 · EY · contact PI
Understanding the pathogenesis of and identifying treatments for albinism$1,026,020
ZIA · FY2025 · EY · contact PI
Natural History of ABCA4-Related Retinopathies$615,612
ZIA · FY2025 · EY · contact PI
The Genetics of Uveal Coloboma$1,846,858
ZIA · FY2024 · EY · contact PI
Understanding the pathogenesis of and identifying treatments for albinism$1,175,643
ZIA · FY2024 · EY · contact PI
Natural History of ABCA4-Related Retinopathies$756,642
ZIA · FY2024 · EY · contact PI
The Genetics of Uveal Coloboma$1,670,538
ZIA · FY2023 · EY · contact PI
Pre-clinical and clinical studies of NTBC and other compounds as potential treatments for albinism$1,035,426
ZIA · FY2023 · EY · contact PI
Natural History of ABCA4-Related Retinopathies$754,436
ZIA · FY2023 · EY · contact PI
The Genetics of Uveal Coloboma$3,119,089
ZIA · FY2022 · EY · contact PI
Pre-clinical and clinical studies of NTBC and other compounds as potential treatments for albinism$1,519,287
ZIA · FY2022 · EY · contact PI
Natural History of ABCA4-Related Retinopathies$686,130
ZIA · FY2022 · EY · contact PI
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)$266,050
ZIA · FY2022 · EY · contact PI
The Genetics of Uveal Coloboma$2,652,839
ZIA · FY2021 · EY · contact PI
Pre-clinical and clinical studies of NTBC and other compounds as potential treatments for albinism$1,414,848
ZIA · FY2021 · EY · contact PI
Natural History of ABCA4-Related Retinopathies$735,348
ZIA · FY2021 · EY · contact PI
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)$223,397
ZIA · FY2021 · EY · contact PI
The Genetics of Uveal Coloboma$2,860,535
ZIA · FY2020 · EY · contact PI
Pre-clinical and clinical studies of NTBC and other compounds as potential treatments for albinism$1,023,709
ZIA · FY2020 · EY · contact PI
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)$552,803
ZIA · FY2020 · EY · contact PI
Natural History of ABCA4-Related Retinopathies$201,817
ZIA · FY2020 · EY · contact PI
The Genetics of Uveal Coloboma$2,632,856
ZIA · FY2019 · EY · contact PI
Pre-clinical and clinical studies of NTBC and other compounds as potential treatments for albinism$906,077
ZIA · FY2019 · EY · contact PI
Natural History of ABCA4-Related Retinopathies$831,718
ZIA · FY2019 · EY · contact PI
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)$275,403
ZIA · FY2019 · EY · contact PI
The Genetics of Uveal Coloboma$2,837,831
ZIA · FY2018 · EY · contact PI
Natural History of ABCA4-Related Retinopathies$693,813
ZIA · FY2018 · EY · contact PI
Pre-clinical and clinical studies of NTBC and other compounds as potential treatments for albinism$571,375
ZIA · FY2018 · EY · contact PI
Ophthalmic Genetics Fellowship$489,750
ZIE · FY2018 · EY · contact PI
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)$272,084
ZIA · FY2018 · EY · contact PI
The Genetics of Uveal Coloboma$3,079,493
ZIA · FY2017 · EY · contact PI
Ophthalmic Genetics Fellowship$693,083
ZIE · FY2017 · EY · contact PI
Pre-clinical and clinical studies of NTBC and other compounds as potential treatments for albinism$509,311
ZIA · FY2017 · EY · contact PI
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)$26,253
ZIA · FY2017 · EY · contact PI
Natural History of ABCA4-Related Retinopathies$13,127
ZIA · FY2017 · EY · contact PI
The Genetics of Uveal Coloboma$1,477,278
ZIA · FY2016 · EY · contact PI
Ophthalmic Genetics Fellowship$718,960
ZIE · FY2016 · EY · contact PI
Pre-clinical and clinical studies of NTBC as a potential treatment for albinism$485,429
ZIA · FY2016 · EY · contact PI
Generation of Induced Pluripotent Stem (iPS) Cell Lines from Somatic Cells of Participants with Eye Diseases and from Somatic Cells of Matched Controls$78,718
ZIA · FY2016 · EY · contact PI
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)$26,239
ZIA · FY2016 · EY · contact PI
Natural History of ABCA4-Related Retinopathies$13,120
ZIA · FY2016 · EY · contact PI
The Genetics of Uveal Coloboma$1,349,233
ZIA · FY2015 · EY · contact PI
Pre-clinical and clinical studies of NTBC as a potential treatment for albinism$411,351
ZIA · FY2015 · EY · contact PI
Ophthalmic Genetics Fellowship$364,340
ZIE · FY2015 · EY · contact PI
Generation of Induced Pluripotent Stem (iPS) Cell Lines from Somatic Cells of Participants with Eye Diseases and from Somatic Cells of Matched Controls$70,517
ZIA · FY2015 · EY · contact PI
Natural History of ABCA4-Related Retinopathies$11,753
ZIA · FY2015 · EY · contact PI
The Genetics of Uveal Coloboma$1,580,798
ZIA · FY2014 · EY · contact PI
Ophthalmic Genetics Fellowship$521,275
ZIE · FY2014 · EY · contact PI
Pre-clinical and clinical studies of NTBC as a potential treatment for albinism$460,662
ZIA · FY2014 · EY · contact PI
Generation of Induced Pluripotent Stem (iPS) Cell Lines from Somatic Cells of Participants with Eye Diseases and from Somatic Cells of Matched Controls$145,472
ZIA · FY2014 · EY · contact PI
Natural History of ABCA4-Related Retinopathies$12,123
ZIA · FY2014 · EY · contact PI
The Genetics of Uveal Coloboma$1,657,107
ZIA · FY2013 · EY · contact PI
Pre-clinical and clinical studies of NTBC as a potential treatment for albinism$543,701
ZIA · FY2013 · EY · contact PI
Ophthalmic Genetics Fellowship$508,243
ZIE · FY2013 · EY · contact PI
Natural History of ABCA4-Related Retinopathies$11,820
ZIA · FY2013 · EY · contact PI
The Genetics of Uveal Coloboma$1,899,366
ZIA · FY2012 · EY · contact PI
Ophthalmic Genetics Fellowship$547,894
ZIE · FY2012 · EY · contact PI
Pre-clinical studies of NTBC as a potential treatment for albinism$535,719
ZIA · FY2012 · EY · contact PI
The Genetics of Uveal Coloboma$1,507,796
ZIA · FY2011 · EY · contact PI
Ophthalmic Genetics Fellowship$439,227
ZIE · FY2011 · EY · contact PI
Pre-clinical studies of NTBC as a potential treatment for albinism$327,782
ZIA · FY2011 · EY · contact PI
The Genetics of Uveal Coloboma$1,435,953
ZIA · FY2010 · EY · contact PI
Pre-clinical studies of NTBC as a potential treatment for albinism$312,164
ZIA · FY2010 · EY · contact PI
Ophthalmic Genetics Fellowship$121,744
ZIE · FY2010 · EY · contact PI
CRX-mediated Leber Congenital Amaurosis$62,433
ZIA · FY2010 · EY · contact PI
The Genetics of Uveal Coloboma$1,316,859
ZIA · FY2009 · EY · contact PI
CRX-mediated Leber Congenital Amaurosis$398,120
ZIA · FY2009 · EY · contact PI
Pre-clinical studies of NTBC as a potential treatment for albinism$306,246
ZIA · FY2009 · EY · contact PI
Ophthalmic Genetics Fellowship$122,498
ZIE · FY2009 · EY · contact PI